Awards Funding Policy

Fiscal Year 2023 Interim Awards Funding Policy – Office of Research Infrastructure Programs

As referenced in NIH Guide Notice (NOT-OD-23-005), the Department of Health and Human Services, including NIH, operates under the Continuing Appropriations and Ukraine Supplemental Appropriations Act (Public Law 117-180) signed by President Biden on September 30, 2022. This Act (CR) continues government operations through December 16, 2022, at the Fiscal Year (FY) 2022 enacted level, with no reduction.

Continuing the procedures identified under NOT-OD-22-045 and consistent with NIH practices during the CRs of FYs 2006 - 2022, NIH Institutes and/or Centers may, at their discretion, issue non-competing research grant awards at a level below that indicated on the most recent Notice of Award. Upward adjustments to awarded levels will be considered after FY 2023 appropriations are enacted, but NIH expects institutions to monitor their expenditures carefully during this period. All legislative mandates that were in effect in FY 2022 (see NOT-OD-22-117) remain in effect under this CR, as well as the salary limitation set at Executive Level II of the Federal Pay Scale (see NOT-OD-22-076) and the Ruth L. Kirschstein National Research Service Award (NRSA) predoctoral and postdoctoral stipend levels and tuition/fees as described in NOT-OD-22-132. The current salary cap levels remain the same until the Executive Salary Levels change; typically, January 2023.

New competing S10, K01, and NRSA Training awards will be issued at Integrated Review Group (IRG)/Council recommended levels minus unallowable costs. All other competing applications selected for funding approval will be funded at 90% of the IRG/Council recommended levels during the CR unless otherwise indicated by grants management and program staff. Non-competing SBIR/STTR, K01, and NRSA Training awards will be issued at 100% of the FY 2022 committed level. All other non-competing continuation applications will be funded at 90% of the previous FY 2022 committed level. Research supplements to promote diversity in health-related research will be issued at program recommended levels minus unallowable costs.

This funding strategy will be updated when FY 2023 appropriations are enacted, and final funding policies are determined. Upward adjustments to awarded levels will be considered after FY 2023 appropriations are enacted

Awards Funding Policy Archives

Last updated: 10-28-2022